122 related articles for article (PubMed ID: 3325818)
41. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children.
Rolinck-Werninghaus C; Hamelmann E; Keil T; Kulig M; Koetz K; Gerstner B; Kuehr J; Zielen S; Schauer U; Kamin W; Von Berg A; Hammermann J; Weinkauf B; Weidinger G; Stenglein S; Wahn U;
Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906
[TBL] [Abstract][Full Text] [Related]
42. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
[TBL] [Abstract][Full Text] [Related]
43. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses.
McHugh SM; Lavelle B; Kemeny DM; Patel S; Ewan PW
J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):521-31. PubMed ID: 1699985
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
45. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
[TBL] [Abstract][Full Text] [Related]
46. Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy.
Peng ZK; Naclerio RM; Norman PS; Adkinson NF
J Allergy Clin Immunol; 1992 Feb; 89(2):519-29. PubMed ID: 1740582
[TBL] [Abstract][Full Text] [Related]
47. Specific IgE, IgG and IgG4 antibodies against house dust mite in patients with bronchial asthma.
Okazaki M; Kitani H; Mifune T; Mitsunobu F; Asaumi N; Tanizaki Y; Harada H; Takahashi K; Kimura I
Acta Med Okayama; 1991 Aug; 45(4):267-73. PubMed ID: 1962533
[TBL] [Abstract][Full Text] [Related]
48. A study of the human immune response to Lolium perenne (rye) pollen and its components, Lol p I and Lol p II (Rye I and Rye II). II. Longitudinal variation of antibody levels in relation to symptomatology and pollen exposure and correction of seasonally elevated antibody levels to basal values.
Freidhoff LR; Ehrlich-Kautzky E; Meyers DA; Marsh DG
J Allergy Clin Immunol; 1987 Nov; 80(5):646-55. PubMed ID: 3680810
[TBL] [Abstract][Full Text] [Related]
49. Timothy-specific IgG antibody levels vary with the pollen seasons.
Nordvall SL; Larsson PH; Johansson SG
Allergy; 1986 Nov; 41(8):575-80. PubMed ID: 3812929
[TBL] [Abstract][Full Text] [Related]
50. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
[TBL] [Abstract][Full Text] [Related]
51. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy.
Djurup R
Allergy; 1985 Oct; 40(7):469-86. PubMed ID: 3907393
[TBL] [Abstract][Full Text] [Related]
52. In vitro basophil histamine-releasing activity of circulating IgG1 and IgG4 autoanti-IgE antibodies from asthma patients and the demonstration that anti-IgE modulates allergen-induced basophil activation.
Shakib F; Smith SJ
Clin Exp Allergy; 1994 Mar; 24(3):270-5. PubMed ID: 7516815
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
Worm M
Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
[TBL] [Abstract][Full Text] [Related]
54. Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study.
Leynadier F; Banoun L; Dollois B; Terrier P; Epstein M; Guinnepain MT; Firon D; Traube C; Fadel R; André C
Clin Exp Allergy; 2001 Jul; 31(7):988-96. PubMed ID: 11467988
[TBL] [Abstract][Full Text] [Related]
55. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy.
Aberer W; Hawranek T; Reider N; Schuster C; Sturm G; Kränke B
J Investig Allergol Clin Immunol; 2007; 17(3):131-6. PubMed ID: 17583098
[TBL] [Abstract][Full Text] [Related]
56. Allergen-specific immunotherapy with recombinant grass pollen allergens.
Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
[TBL] [Abstract][Full Text] [Related]
57. Specific cellular and humoral immunity in children with grass pollen asthma.
Hill DJ; Smart IJ; Hosking CS
Clin Allergy; 1982 Jan; 12(1):83-9. PubMed ID: 7067069
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response.
Birkner T; Rumpold H; Jarolim E; Ebner H; Breitenbach M; Skvaril F; Scheiner O; Kraft D
Allergy; 1990 Aug; 45(6):418-26. PubMed ID: 2244672
[TBL] [Abstract][Full Text] [Related]
59. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass.
Hussain R; Poindexter RW; Ottesen EA
J Immunol; 1992 May; 148(9):2731-7. PubMed ID: 1573266
[TBL] [Abstract][Full Text] [Related]
60. Specific IgG antibodies (total and subclasses) against Saffron pollen: a study of their correlation with specific IgE and immediate skin reactions.
Varasteh AR; Vahedi F; Sankian M; Kaghazian H; Tavallaie S; Abolhassani A; Kermani T; Mahmoudi M
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):189-95. PubMed ID: 18094441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
